Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 99-104

  Matsuyama, Masahide ^a   Hayama, Takuma ^a   Funao, Kiyoaki ^a   Kawahito, Yutaka ^b   Sano, Hajime ^c   Takemoto, Yoshiaki ^a   Nakatani, Tatsuya ^a   Yoshimura, Rikio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Apoptosis; Prostate cancer

Indexed keywords

ACETIC ACID DERIVATIVE; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEMBRANE PROTEIN; MONTELUKAST; QUINOLINE DERIVATIVE;

AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ACETATES; AGED; APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOTRIENE ANTAGONISTS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; QUINOLINES; RECEPTORS, LEUKOTRIENE; TUMOR CELLS, CULTURED;

EID: 34548018348     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.99     Document Type: Article

References (15)

1. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992.
2. Yoshimura R, Sano H, Masuda C, et al: Expression of cyclooxygenase-2 in human prostate cancer. Cancer 89: 589-596, 2000. (Pubitemid 30640105)
3. Matsuyama M, Yoshimura R, Mitsuhashi M, et al: Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol 24: 821-827, 2004.
4. Lynch KR, O'Neill GP, Liu G, et al: Characterization of human cysteinyl leukotriene CysLT1 receptor. Nature 399: 789-793, 1999. (Pubitemid 29293175)
5. Ohd JF, Wikstrom K and Sjolander A: Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119: 1007-1018, 2000
6. Nielsen CK, Campbell JI, Ohd JF, et al: A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65: 732-742, 2005. (Pubitemid 40220345)
7. Matsuyama M, Yoshimura R, Mitsuhashi M, et al: 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway. Oncol Rep 14: 73-79, 2005.
8. Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H and Nakatani T: Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 170: 1994-1999, 2003. (Pubitemid 37254995)
9. Yoshimura R, Matsuyama M, Mitsuhashi M, et al: Relationship between lipoxygenase and human testicular cancer. Int J Mol Med 13: 389-393, 2004.
10. Sano H, Hla T, Maier JAM, et al: In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89: 97-108, 1992.
11. Fitzgerald SM and Flinn S: Evaluating research studies using the analysis of variance (ANOVA): issues and interpretations. J Hand Ther 13: 56-60, 2000. (Pubitemid 30134138)
12. Horwitz RJ, McGill KA and Busse WW: The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med 157: 1363-1371, 1998.
13. Wenzel SE: New approaches to anti-inflammatory therapy for asthma. Am J Med 104: 287-300, 1998.
14. Drazen J: Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 157: 233-237, 1998.
15. Matsuyama M, Yoshimura R, Tsuchida K, et al: Lipoxygenase inhibitors prevent urological cancer cell growth. Int J Mol Med 13: 665-668, 2004.